Clinical limitations of acetylcholinesterase antagonists

Journal of Critical Care

Volumn 24, Issue 1, 2009, Pages 21-28

  Caldwell, James E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylcholine; Neuromuscular block; Reversal

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ATRACURIUM; ATROPINE; CISATRACURIUM; EDROPHONIUM; GLYCOPYRRONIUM BROMIDE; MUSCLE RELAXANT AGENT; NEOSTIGMINE; PYRIDOSTIGMINE; TUBOCURARINE CHLORIDE; VECURONIUM;

BINDING SITE; BRADYCARDIA; BRONCHODILATATION; BRONCHOSPASM; DIAPHRAGM MOVEMENT; DOSE RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG EFFICACY; DRUG MEGADOSE; ENZYME BINDING; ENZYME INHIBITION; ENZYME METABOLISM; ERYTHROCYTE; GASTROINTESTINAL MOTILITY; GENIOGLOSSUS MUSCLE; HEART RATE; HUMAN; HYDROLYSIS KINETICS; MORBIDITY; MORTALITY; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; NAUSEA AND VOMITING; NEUROMUSCULAR BLOCKING; NONHUMAN; PARASYMPATHETIC FUNCTION; PRESSORECEPTOR REFLEX; PROTEIN METABOLISM; REVIEW; SIDE EFFECT;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANESTHESIA RECOVERY PERIOD; ANIMALS; BINDING, COMPETITIVE; CHOLINESTERASE INHIBITORS; DRUG MONITORING; ELECTRIC STIMULATION; HUMANS; MONITORING, INTRAOPERATIVE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RATS; RECEPTORS, MUSCARINIC;

EID: 61449106490     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2008.08.003     Document Type: Review

References (74)

1. Martyn J.A.J., Standaert F.J., and Miller R.D. In: Miller R.D. (Ed). Neuromuscular physiology and pharmacology, anesthesia (2000), Churchill Livingstone, Philadelphia 735-751
2. Prior C.B., and Marshall I.G. In: Hemmings H.C.s., and Hopkins P.M. (Eds). Neuromuscular junction physiology, foundations of anesthesia (2006), Elsevier, Philadelphia 435-443
3. Jonsson M., Gurley D., Dabrowski M., et al. Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade. Anesthesiology 105 (2006) 521-533
4. Bowman W.C. In: Fukushima K., and Ochiai R. (Eds). Mechanisms of action of reversal agents, muscle relaxants: physiologic and pharmacologic aspects (1995), Springer-Verlag, Tokyo 19-30
5. Mirakhur R.K. In: Goldhill D.R., and Flynn P.J. (Eds). Antagonism of neuromuscular blockade, Bailliere's clinical anesthesiology: muscle relaxants (1994), Bailliere Tindall, London 461-481
6. Mirakhur R.K., and McCarthy G.J. Basic pharmacology of reversal agents. Anesth Clin North Am 11 (1993) 237
7. Bevan D.R., Bevan J.C., and Donati F. Pharmacodynamic principles, muscle relaxants. In: Bevan D.R., Bevan J.C., and Donati F. (Eds). Clinical anesthesia (1988), Year Book Medical Publishers Inc., Chicago 71-99
8. Bevan D.R., Bevan J.C., and Donati F. Muscle relaxants in clinical anesthesia (1988), Year Book Medical Publishers, Chicago
9. Bartkowski R.R. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium. Anesth Analg 66 (1987) 594-598
10. Barber H.E., Calvey T.N., and Muir K.T. The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium. Br J Pharmacol 66 (1979) 525-530
11. Morris R.B., Cronnelly R., Miller R.D., et al. Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man. Anesthesiology 54 (1981) 399-401
12. Cronnelly R., Morris R.B., and Miller R.D. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia. Anesthesiology 57 (1982) 261-266
13. Donati F., Smith C.E., and Bevan D.R. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade. Anesth Analg 68 (1989) 13-19
14. Kopman A.F. In: Rupp S.M. (Ed). Antagonism of profound neuromuscular blockade, problems in anesthesia: neuromuscular relaxants (1989), J.B. Lippincott Company, Philadelphia 405-420
15. Eriksson L.I. Residual neuromuscular blockade. Incidence and relevance. Anaesthesist 49 Suppl 1 (2000) S18-S19
16. Caldwell J.E., Robertson E.N., and Baird W.L. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium. Br J Anaesth 58 (1986) 1285-1289
17. Magorian T.T., Lynam D.P., Caldwell J., et al. Can early administration of neostigmine, in single or divided doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade?. Anesthesiology 73 (1990) 410-414
18. Bevan D.R., Smith C.E., and Donati F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology 69 (1988) 272-276
19. Murphy G.S. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol 72 (2006) 97-109
20. Murphy G.S., Szokol J.W., Marymont J.H., et al. Residual paralysis at the time of tracheal extubation. Anesth Analg 100 (2005) 1840-1845
21. Ali H., Savarese J., Lewbowitz P., et al. Twitch, tetanus and train-of-four as indices of recovery from nondepolarizing neuromuscular blockade. Anesthesiology 54 (1981) 294-297
22. Brand J.B., Cullen D.J., Wilson N.E., et al. Spontaneous recovery from nondepolarizing neuromuscular blockade: correlation between clinical and evoked responses. Anesth Analg 56 (1977) 55-58
23. Naguib M., Kopman A.F., and Ensor J.E. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth 98 (2007) 302-316
24. Eriksson L.I., Sundman E., Olsson R., et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 87 (1997) 1035-1043
25. Kopman A.F., Yee P.S., and Neuman G.G. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 86 (1997) 765-771
26. Sundman E., Witt H., Olsson R., et al. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 92 (2000) 977-984
27. Kirkegaard H., Heier T., and Caldwell J.E. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 96 (2002) 45-50
28. Baillard C., Clec'h C., Catineau J., et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth 95 (2005) 622-626
29. Fruergaard K., Viby-Mogensen J., Berg H., et al. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis. Acta Anaesthesiol Scand 42 (1998) 1168-1174
30. Gatke M.R., Viby-Mogensen J., Rosenstock C., et al. Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand 46 (2002) 207-213
31. Hayes A.H., Mirakhur R.K., Breslin D.S., et al. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 56 (2001) 312-318
32. Barth C.D., and Ebert T.J. In: Hemmings H.C.S., and Hopkins P.M. (Eds). Autonomic nervous system, foundations of anesthesia (2006), Elsevier, Philadelphia 403-417
33. Clutton R.E., Boyd C., Flora R., et al. Autonomic and cardiovascular effects of neuromuscular blockade antagonism in the dog. Vet Surg 21 (1992) 68-75
34. Triantafillou A.N., Tsueda K., Berg J., et al. Refractory bradycardia after reversal of muscle relaxant in a diabetic with vagal neuropathy. Anesth Analg 65 (1986) 1237-1241
35. Kido K., Mizuta K., Mizuta F., et al. Coronary vasospasm during the reversal of neuromuscular block using neostigmine. Acta Anaesthesiol Scand 49 (2005) 1395-1396
36. Muir A.W., Houston J., Marshall R.J., et al. A comparison of the neuromuscular blocking and autonomic effects of two new short-acting muscle relaxants with those of succinylcholine in the anesthetized cat and pig. Anesthesiology 70 (1989) 533-540
37. van Vlymen J.M., and Parlow J.L. The effects of reversal of neuromuscular blockade on autonomic control in the perioperative period. Anesth Analg 84 (1997) 148-154
38. Cozanitis D.A., Dundee J.W., Merrett J.D., et al. Evaluation of glycopyrrolate and atropine as adjuncts to reversal of non-depolarizing neuromuscular blocking agents in a "true-to-life" situation. Br J Anaesth 52 (1980) 85-89
39. Mirakhur R.K., Dundee J.W., and Clarke R.S. Glycopyrrolate-neostigmine mixture for antagonism of neuromuscular block: comparison with atropine-neostigmine mixture. Br J Anaesth 49 (1977) 825-829
40. Mirakhur R.K., Dundee J.W., Jones C.J., et al. Reversal of neuromuscular blockade: dose determination studies with atropine and glycopyrrolate given before or in a mixture with neostigmine. Anesth Analg 60 (1981) 557-562
41. Radulovic M., Spungen A.M., Wecht J.M., et al. Effects of neostigmine and glycopyrrolate on pulmonary resistance in spinal cord injury. J Rehabil Res Dev 41 (2004) 53-58
42. Berg H., Roed J., Viby-Mogensen J., et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 41 (1997) 1095-1103
43. Cheng C.R., Sessler D.I., and Apfel C.C. Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting?. Anesth Analg 101 (2005) 1349-1355
44. Gan T.J. Risk factors for postoperative nausea and vomiting. Anesth Analg 102 (2006) 1884-1898
45. Lovstad R.Z., Thagaard K.S., Berner N.S., et al. Neostigmine 50 microg kg(-1) with glycopyrrolate increases postoperative nausea in women after laparoscopic gynaecological surgery. Acta Anaesthesiol Scand 45 (2001) 495-500
46. Olivieri L., Pierdominici S., Testa G., et al. Dehiscence of intestinal anastomoses and anaesthesia. Ital J Surg Sci 18 (1988) 217-221
47. Buzello W., Krieg N., and Brobmann G.F. [Neostigmine and dehiscence of intestinal anastomoses (author's transl)]. Anasth Intensivther Notfallmed 17 (1982) 81-85
48. Garcia-Olmo D.C., Garcia-Rivas M., and Garcia-Olmo D. Does neostigmine have a deleterious effect on the resistance of colonic anastomoses?. Eur J Anaesthesiol 15 (1998) 38-43
49. Payne J.P., Hughes R., and Al Azawi S. Neuromuscular blockade by neostigmine in anaesthetized man. Br J Anaesth 52 (1980) 69-76
50. Astley B.A., Katz R.L., and Payne J.P. Electrical and mechanical responses after neuromuscular blockade with vecuronium, and subsequent antagonism with neostigmine or edrophonium. Br J Anaesth 59 (1987) 983-988
51. Caldwell J.E. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesth Analg 80 (1995) 1168-1174
52. Goldhill D.R., Wainwright A.P., Stuart C.S., et al. Neostigmine after spontaneous recovery from neuromuscular blockade. Effect on depth of blockade monitored with train-of-four and tetanic stimuli. Anaesthesia 44 (1989) 293-299
53. Eikermann M., Fassbender P., Malhotra A., et al. Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function. Anesthesiology 107 (2007) 621-629
54. Arbous M.S., Meursing A.E., van Kleef J.W., et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 102 (2005) 257-268 quiz 491-2
55. Debaene B., Plaud B., Dilly M.P., et al. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 98 (2003) 1042-1048
56. Beemer G.H., Bjorksten A.R., Dawson P.J., et al. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. Br J Anaesth 66 (1991) 469-475
57. Beemer G.H., Goonetilleke P.H., and Bjorksten A.R. The maximum depth of an atracurium neuromuscular block antagonized by edrophonium to effect adequate recovery. Anesthesiology 82 (1995) 852-858
58. Katz R.L. Neuromuscular effects of d-tubocurarine, edrophonium and neostigmine in man. Anesthesiology 28 (1967) 327-336
59. Morita T., Tsukagoshi H., Sugaya T., et al. Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesia. Anesth Analg 80 (1995) 1175-1180
60. Kirkegaard-Nielsen H., Caldwell J.E., Abengochea A., et al. Does discontinuation of desflurane at the time of neostigmine administration speed recovery from cisatracurium block compared to that with a propofol-based technique?. Acta Anaesthesiol Scand 45 (2001) 618-623
61. Biro K. Effects of respiratory and metabolic alkalosis and acidosis on pipecuronium neuromuscular block. Eur J Pharmacol 154 (1988) 329-333
62. Wirtavuori K., Salmenpera M., and Tammisto T. Effect of hypocarbia and hypercarbia on the antagonism of pancuronium-induced neuromuscular blockade with neostigmine in man. Br J Anaesth 54 (1982) 57-61
63. Saitoh Y., Hattori H., Sanbe N., et al. Reversal of vecuronium with neostigmine in patients with diabetes mellitus. Anaesthesia 59 (2004) 750-754
64. Suzuki T., Masaki G., and Ogawa S. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. Br J Anaesth 97 (2006) 160-163
65. Pogson D., Telfer J., and Wimbush S. Prolonged vecuronium neuromuscular blockade associated with Charcot Marie Tooth neuropathy. Br J Anaesth 85 (2000) 914-917
66. Bouw J., Leendertse K., Tijssen M.A., et al. Stiff person syndrome and anesthesia: case report. Anesth Analg 97 (2003) 486-487 table of contents
67. Sun K.O. Central anticholinergic syndrome following reversal of neuromuscular blockade. Anaesth Intensive Care 21 (1993) 363-365
68. Fawcett W.J., and Stone J.P. Recurarization in the recovery room following the use of magnesium sulphate. Br J Anaesth 91 (2003) 435-438
69. Takiguchi M., and Takaya T. Potentiation of neuromuscular blockade by calcium channel blockers. Tokai J Exp Clin Med 19 (1994) 131-137
70. Jones R.M., Cashman J.N., Casson W.R., et al. Verapamil potentiation of neuromuscular blockade: failure of reversal with neostigmine but prompt reversal with edrophonium. Anesth Analg 64 (1985) 1021-1025
71. Hasfurther D.L., and Bailey P.L. Failure of neuromuscular blockade reversal after rocuronium in a patient who received oral neomycin. Can J Anaesth 43 (1996) 617-620
72. Kronenfeld M.A., Thomas S.J., and Turndorf H. Recurrence of neuromuscular blockade after reversal of vecuronium in a patient receiving polymyxin/amikacin sternal irrigation. Anesthesiology 65 (1986) 93-94
73. Heier T., Caldwell J.E., Sessler D.I., et al. Mild intraoperative hypothermia increases duration of action and spontaneous recovery of vecuronium blockade during nitrous oxide-isoflurane anesthesia in humans. Anesthesiology 74 (1991) 815-819
74. Heier T., Clough D., Wright P.M., et al. The influence of mild hypothermia on the pharmacokinetics and time course of action of neostigmine in anesthetized volunteers. Anesthesiology 97 (2002) 90-95